Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-32727337

RESUMEN

The current treatment and prevention procedures of oral disorders follow a very targeted approach considering mouth and its structures as a system that is completely independent, than the rest of the body. The main therapeutic approach is to keep the levels of oral bacteria and hygiene in an acceptable range compatible with oral-mouth health, completely separated from systemic microbial homeostasis (eubiosis vs dysbiosis). This can negatively impact the diagnosis of a more complex systemic disease and its progression. Dysbiosis occurs as a consequence of imbalance in oral and gut microbiota which leads to cardiovascular diseases, diabetes mellitus, rheumatoid arthritis, and Alzheimer's disease, as reported in current literature. Likewise, there is a need to highlight and develop a novel philosophical approach in the treatments for oral diseases that will necessarily involve nonconventional approaches.


Asunto(s)
Disbiosis/microbiología , Enfermedades del Sistema Endocrino/microbiología , Microbioma Gastrointestinal , Enfermedades del Sistema Inmune/microbiología , Enfermedades Metabólicas/microbiología , Mucosa Bucal/microbiología , Animales , Disbiosis/terapia , Enfermedades del Sistema Endocrino/terapia , Ácidos Grasos/administración & dosificación , Ácidos Grasos/efectos adversos , Microbioma Gastrointestinal/efectos de los fármacos , Microbioma Gastrointestinal/fisiología , Tracto Gastrointestinal , Humanos , Enfermedades del Sistema Inmune/terapia , Enfermedades Metabólicas/terapia , Microbiota/efectos de los fármacos , Microbiota/fisiología , Mucosa Bucal/fisiología , Probióticos/administración & dosificación
2.
Biochem Soc Trans ; 48(3): 915-931, 2020 06 30.
Artículo en Inglés | MEDLINE | ID: mdl-32412045

RESUMEN

Type 1 diabetes (T1D) and Hashimoto's thyroiditis (HT) are the two most common autoimmune endocrine diseases that have rising global incidence. These diseases are caused by the immune-mediated destruction of hormone-producing endocrine cells, pancreatic beta cells and thyroid follicular cells, respectively. Both genetic predisposition and environmental factors govern the onset of T1D and HT. Recent evidence strongly suggests that the intestinal microbiota plays a role in accelerating or preventing disease progression depending on the compositional and functional profile of the gut bacterial communities. Accumulating evidence points towards the interplay between the disruption of gut microbial homeostasis (dysbiosis) and the breakdown of host immune tolerance at the onset of both diseases. In this review, we will summarize the major recent findings about the microbiome alterations associated with T1D and HT, and the connection of these changes to disease states. Furthermore, we will discuss the potential mechanisms by which gut microbial dysbiosis modulates the course of the disease, including disruption of intestinal barrier integrity and microbial production of immunomodulatory metabolites. The aim of this review is to provide broad insight into the role of gut microbiome in the pathophysiology of these diseases.


Asunto(s)
Enfermedades del Sistema Endocrino/metabolismo , Microbioma Gastrointestinal , Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/microbiología , Ácidos y Sales Biliares/metabolismo , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/microbiología , Progresión de la Enfermedad , Disbiosis/inmunología , Disbiosis/microbiología , Enfermedades del Sistema Endocrino/inmunología , Enfermedades del Sistema Endocrino/microbiología , Ácidos Grasos Volátiles/metabolismo , Predisposición Genética a la Enfermedad , Enfermedad de Hashimoto/inmunología , Enfermedad de Hashimoto/microbiología , Homeostasis , Humanos , Incidencia , Permeabilidad
3.
Nutrients ; 12(3)2020 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-32182980

RESUMEN

Human microbiota seems to play a key role in endocrine and reproductive systems. Fortunately, microbiota reproductive dysbiosis start to be treated by probiotics using typical species from genus Lactobacillus. This work presents the compiled and analysed results from the most up-to-date information from clinical trials regarding microbiota, fertility, probiotics and oral route administration, reviewing open access scientific documents. These studies analyse the clinical impact of probiotics administered on several endocrine disorders' manifestations in women: mastitis; vaginal dysbiosis; pregnancy complication disorders; and polycystic ovary syndrome. In all cases, the clinical modulation achieved by probiotics was evaluated positively through the improvement of specific disease outcomes with the exception of the pregnancy disorders studies, where the sample sizes results were statistically insufficient. High amounts of studies were discarded because no data were provided on specific probiotic strains, doses, impact on the individual autochthon microbiota, or data regarding specific hormonal values modifications and endocrine regulation effects. However, most of the selected studies with probiotics contained no protocolised administration. Therefore, we consider that intervention studies with probiotics might allocate the focus, not only in obtaining a final outcome, but in how to personalise the administration according to the disorder to be palliated.


Asunto(s)
Suplementos Dietéticos , Disbiosis/terapia , Enfermedades del Sistema Endocrino/terapia , Infertilidad Femenina/terapia , Probióticos/uso terapéutico , Disbiosis/complicaciones , Sistema Endocrino/microbiología , Enfermedades del Sistema Endocrino/microbiología , Femenino , Genitales Femeninos/microbiología , Humanos , Infertilidad Femenina/microbiología , Microbiota , Embarazo , Resultado del Tratamiento
4.
World J Gastroenterol ; 15(22): 2701-7, 2009 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-19522019

RESUMEN

Helicobacter pylori (H pylori) infection is a leading world-wide infectious disease as it affects more than half of the world population and causes chronic gastritis, peptic ulcer disease and gastric malignancies. The infection elicits a chronic cellular inflammatory response in the gastric mucosa. However, the effects of this local inflammation may not be confined solely to the digestive tract but may spread to involve extra-intestinal tissues and/or organs. Indeed, H pylori infection has been epidemiologically linked to extra-digestive conditions and diseases. In this context, it has been speculated that H pylori infection may be responsible for various endocrine disorders, such as autoimmune thyroid diseases, diabetes mellitus, dyslipidemia, obesity, osteoporosis and primary hyperparathyroidism. This is a review of the relationship between H pylori infection and these endocrine disorders.


Asunto(s)
Enfermedades del Sistema Endocrino , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori/metabolismo , Diabetes Mellitus/microbiología , Diabetes Mellitus/fisiopatología , Dislipidemias/microbiología , Dislipidemias/fisiopatología , Enfermedades del Sistema Endocrino/microbiología , Enfermedades del Sistema Endocrino/fisiopatología , Humanos , Hiperparatiroidismo/microbiología , Hiperparatiroidismo/fisiopatología , Obesidad/microbiología , Obesidad/fisiopatología , Osteoporosis/microbiología , Osteoporosis/fisiopatología , Enfermedades de la Tiroides/microbiología , Enfermedades de la Tiroides/fisiopatología
5.
Stomatologiia (Mosk) ; 80(4): 24-7, 2001.
Artículo en Ruso | MEDLINE | ID: mdl-11561529

RESUMEN

Sixty-two patients with cardiovascular, gastrointestinal, and endocrine diseases aged over 60 years and 27 healthy young people aged 16-18 years (controls) were examined in order to evaluate the qualitative composition and dissemination of oral microflora in elderly people with general somatic diseases. Microbiological study revealed changes in the qualitative composition and dissemination of the oral mucosa microflora, which depended on patient's age, disease, and treatment administered for somatic disease.


Asunto(s)
Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/microbiología , Adolescente , Factores de Edad , Anciano , Fenómenos Fisiológicos Bacterianos/efectos de los fármacos , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/microbiología , Enfermedades del Sistema Digestivo/complicaciones , Enfermedades del Sistema Digestivo/tratamiento farmacológico , Enfermedades del Sistema Digestivo/microbiología , Enfermedades del Sistema Endocrino/complicaciones , Enfermedades del Sistema Endocrino/tratamiento farmacológico , Enfermedades del Sistema Endocrino/microbiología , Humanos , Persona de Mediana Edad
7.
Baillieres Clin Endocrinol Metab ; 9(1): 47-70, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7726798

RESUMEN

The literature examined in this review points to the possible involvement of infectious agents in the pathogenesis of autoimmune endocrine diseases, primarily autoimmune thyroid disease and diabetes mellitus. Various mechanisms have been proposed to explain induction of autoimmunity by infection but it seems that three possibilities may be important in individuals susceptible to developing autoimmune disease: molecular mimicry (perhaps to retroviruses); polyclonal T cell activation (by an endogenous superantigen or an infecting organism); and MHC class II antigen induction. It seems reasonable that all three mechanisms operate together or separately in different individuals. Data continue to accumulate in favour of infectious agents being important initiators of autoimmune disease.


Asunto(s)
Enfermedades Autoinmunes , Enfermedades del Sistema Endocrino/inmunología , Infecciones , Animales , Autoantígenos , Diabetes Mellitus/genética , Diabetes Mellitus/inmunología , Diabetes Mellitus/microbiología , Enfermedades del Sistema Endocrino/microbiología , Antígenos de Histocompatibilidad , Humanos , Enfermedades de la Tiroides/inmunología , Enfermedades de la Tiroides/microbiología , Virosis
10.
Lancet ; 2(8359): 1115-9, 1983 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-6138647

RESUMEN

Immune responses are initiated by HLA-DR+ cells, which present antigen to T cells. Observations that HLA-DR may be experimentally induced on thyroid epithelium and that HLA-DR occurs on thyrocytes in autoimmune thyroid diseases suggest a mechanism of autoimmunity with special relevance to organ-specific diseases. This involves the local aberrant expression of HLA-DR antigens by epithelial cells and their subsequent capacity to present autoantigens occurring on their surfaces to T lymphocytes. For autoantigens which T cells recognise infrequently because of their restricted tissue location and low concentration in the circulation, T-cell tolerance is unlikely, and so induction of autoreactive T cells would occur. Because interferon is the best known inducer of DR antigen expression and viral infections may predate endocrine autoimmunity, the following sequence seems likely: local viral infection which causes interferon production, or other local environmental factors which would induce DR expression, presentation of autoantigens, and subsequent autoimmune T-cell induction. These T cells would activate effector B and T cells. Whether the initial induction of autoimmune T cells leads to autoimmune disease would depend on factors such as abnormalities of the suppressor T-cell pathway, reported to coexist with autoimmunity and necessary to induce autoimmune disease in mice. This mechanism of autoimmune disease induction explains vague associations with viral infections and long latency periods before disease becomes manifest and gives a simple explanation for the well-documented association between HLA-DR and autoimmune diseases in man.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades del Sistema Endocrino/inmunología , Genes MHC Clase II , Antígenos de Histocompatibilidad Clase II/inmunología , Autoantígenos/genética , Autoantígenos/inmunología , Enfermedades Autoinmunes/genética , Enfermedades Autoinmunes/microbiología , Glándulas Endocrinas/inmunología , Enfermedades del Sistema Endocrino/genética , Enfermedades del Sistema Endocrino/microbiología , Antígenos HLA-DR , Humanos , Tolerancia Inmunológica , Modelos Biológicos , Especificidad de Órganos , Linfocitos T/inmunología , Glándula Tiroides/inmunología , Virosis/inmunología
13.
Appl Microbiol ; 23(1): 202, 1972 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-5059621

RESUMEN

Both male and female pigs given a ration containing corn invaded by Fusarium roseum, in amounts sufficient to provide 500 to 600 ppm of F-2, for the first 64 days of the test and which for another 60 days were given a commercial pig ration were much lower in weight than the controls which were given a commercial pig ration throughout. In relation to the weight of the animals, in the pigs receiving the ration containing F-2, the weight of the uterine horn of the gilts was much greater and the weight of the testes of the males was much less than the weight of the same organs of the controls.


Asunto(s)
Fusarium/patogenicidad , Porcinos , Zea mays , Alimentación Animal , Animales , Peso Corporal , Enfermedades del Sistema Endocrino/microbiología , Femenino , Microbiología de Alimentos , Masculino , Tamaño de los Órganos , Testículo , Útero
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA